AU1230992A - Heteroanthracycline antitumor analogs - Google Patents

Heteroanthracycline antitumor analogs

Info

Publication number
AU1230992A
AU1230992A AU12309/92A AU1230992A AU1230992A AU 1230992 A AU1230992 A AU 1230992A AU 12309/92 A AU12309/92 A AU 12309/92A AU 1230992 A AU1230992 A AU 1230992A AU 1230992 A AU1230992 A AU 1230992A
Authority
AU
Australia
Prior art keywords
compound
formula
treatment
group
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12309/92A
Other languages
English (en)
Inventor
Giorgio G Attardo
Bernard Belleau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Biochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/751,092 external-priority patent/US5348946A/en
Application filed by IAF BioChem International Inc, Biochem Pharma Inc filed Critical IAF BioChem International Inc
Publication of AU1230992A publication Critical patent/AU1230992A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/08—Sulfenic acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/60—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU12309/92A 1991-02-28 1992-02-14 Heteroanthracycline antitumor analogs Abandoned AU1230992A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66137691A 1991-02-28 1991-02-28
US661376 1991-02-28
US751092 1991-08-28
US07/751,092 US5348946A (en) 1991-02-28 1991-08-28 Heteroanthracycline antitumor analogs

Publications (1)

Publication Number Publication Date
AU1230992A true AU1230992A (en) 1992-10-06

Family

ID=27098299

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12309/92A Abandoned AU1230992A (en) 1991-02-28 1992-02-14 Heteroanthracycline antitumor analogs

Country Status (12)

Country Link
EP (1) EP0502661A2 (OSRAM)
JP (1) JPH06505007A (OSRAM)
AP (1) AP363A (OSRAM)
AU (1) AU1230992A (OSRAM)
CA (1) CA2104768A1 (OSRAM)
FI (1) FI933777A0 (OSRAM)
IE (1) IE920480A1 (OSRAM)
IL (1) IL100962A0 (OSRAM)
MX (1) MX9200834A (OSRAM)
NO (1) NO933064L (OSRAM)
NZ (1) NZ241606A (OSRAM)
WO (1) WO1992015601A2 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110289A (en) * 1993-08-06 1998-01-04 Policlinico San Matteo Istitut Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis
US9486457B2 (en) 2010-02-23 2016-11-08 The Regents Of The University Of California Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders
BR112021003156A2 (pt) 2018-08-23 2021-05-11 Seagen, Inc. composição, anticorpo que se liga ao tigit humano, formulação farmacêutica, polinucleotídeo isolado, vetor, célula hospedeira, métodos para a produção de um anticorpo que se liga ao tigit humano e de anticorpos afucosilados que se ligam a tigit e para o tratamento de um câncer, e, kit.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS158975B1 (OSRAM) * 1971-11-18 1974-12-27
CS158976B1 (OSRAM) * 1971-11-25 1974-12-27
DE2902177A1 (de) * 1978-12-21 1980-07-17 Bbc Brown Boveri & Cie Fluessigkristallmischung
US4585760A (en) * 1981-07-16 1986-04-29 American Cyanamid Company Dimethylfurano heterocyclic analogs of daunomycin
DE3150629A1 (de) * 1981-12-21 1983-06-30 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 1,2-benzisothiazolin-3-onen
US4530572A (en) * 1982-12-30 1985-07-23 Minnesota Mining And Manufacturing Company Substituted anthraquinone-type isotropic dyes for liquid crystal display devices
CA1269370A (en) * 1986-11-17 1990-05-22 Chiu M. Wong Daunomycin and adriamycin sulfono and sulfoxo analogues
GB2225781A (en) * 1988-05-13 1990-06-13 Erba Carlo Spa 10-Noranthracyclines

Also Published As

Publication number Publication date
JPH06505007A (ja) 1994-06-09
IL100962A0 (en) 1992-11-15
IE920480A1 (en) 1992-09-09
EP0502661A2 (en) 1992-09-09
NO933064L (no) 1993-08-30
NZ241606A (en) 1994-08-26
AP363A (en) 1994-09-23
FI933777L (fi) 1993-08-27
MX9200834A (es) 1992-10-01
FI933777A7 (fi) 1993-08-27
AP9200361A0 (en) 1992-04-30
WO1992015601A3 (en) 1992-10-29
FI933777A0 (fi) 1993-08-27
NO933064D0 (no) 1993-08-27
WO1992015601A2 (en) 1992-09-17
CA2104768A1 (en) 1992-08-29
EP0502661A3 (OSRAM) 1994-03-30

Similar Documents

Publication Publication Date Title
KR910000854B1 (ko) 살균성 화합물의 제조방법
KR100255525B1 (ko) 바카틴 iii 유도체
CA2423568C (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
US5593970A (en) Heterocyclic anthracycline analogs
WO1995012588A1 (en) Antineoplastic heteronaphthoquinones
JP4372843B2 (ja) 坑腫瘍剤として有用なイルジン類似体
US5348946A (en) Heteroanthracycline antitumor analogs
IE904543A1 (en) Morpholinyl derivatives of of doxorubicin and process for¹their preparation
WO1992015601A2 (en) Heteroanthracycline antitumor analogs
US20160075730A1 (en) New morpholinyl anthracycline derivatives
CA1291122C (en) 3'-hydroxy-4'-epi-amino anthracyclines
HUP0004574A2 (hu) 12,13-(Piranozil)-indolo[2,3-a]pirrolo[3,4-c]-karbazol és 12,13-(pirianozil)-furo[3,4-c]indolo[2,3-a]-karbazol, eljárás előállításukra, és ilyen vegyületeket tartalmazó gyógyászati készítmények
AU653348B2 (en) Heterocyclic anthracyclinone and anthracycline analogs
EP0051279B1 (en) Anthracycline glycosides, intermediate compounds, process for preparing both and pharmaceutical compositions
NL8702436A (nl) Anthracycline glycosiden met antitumorwerking, bereiding daarvan, tussenprodukten daarvoor, en preparaten alsmede gebruik daarvan.
Matsuda et al. Synthesis of 14, 14-Difluoro-4-demethoxydaunorubicin.
WO1994011382A1 (en) Antineoplastic heteronaphthoquinones
US5698712A (en) Baccatine III derivatives
AU614698B2 (en) Alkoxymethylidene epipodophyllotoxin glucosides
HRP950436A2 (en) 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them
EP0284380A1 (en) Mitomycin Derivatives
HU209458B (en) Process for preparing 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracyclin derivatives and pharmaceutical compositions containing them as active agents
WO1998025934A1 (en) Dc 107 derivatives (2)
Priebe et al. 3'-Hydroxyesorubicin synthesis and antitumor activity
FI89496B (fi) Foerfarande foer framstaellning av 4-demetoxi-4-aminoantracykliner